companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

BRZOZOWSKI; EDWARD

TAYLOR-USA

Company Name:
Corporate Name:
BRZOZOWSKI; EDWARD
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 10601 Mt. Vernon St. Apt. 203,TAYLOR,MI,USA 
ZIP Code:
Postal Code:
48180 
Telephone Number: 3132928205 (+1-313-292-8205) 
Fax Number:  
Website:
stevesgiftsonline. com 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
729922 
USA SIC Description:
Buyers Information Service 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
B BASEBALL
FUNDAMENTAL BAPTIST MISSIONS INTERNATIONAL
PAUL V. DUDEK
Next company profile:
X-GAMERS.ORG
4-EVER-CLEAR POOLS
TAYLOR DANCE BALLET AMERICANA










Company News:
  • Drug treatment for panic disorder with or without agoraphobia . . .
    Eligibility criteria for study selection Randomised controlled trials that included adults aged ≥18 years with a diagnosis of panic disorder, compared drugs used to treat the panic disorder, and measured the outcomes of interest, including remissions, dropouts, and adverse events
  • Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment . . .
    The outcome of the review reveals a lack of randomized double-blind placebo-controlled trials for anxiety disorders and few studies comparing novel treatments to existing anxiolytic agents
  • Efficacy and safety of aripiprazole or bupropion augmentation and . . .
    To report the first and largest systematic review and meta-analysis of randomized controlled trials (RCT) to evaluate the efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression (TRD) or major depressive dis-order(MDD)
  • Psychotherapies for Generalized Anxiety Disorder in Adults
    This systematic review and network meta-analysis of randomized clinical trials assesses the associations of various psychotherapies with short- and long-term effectiveness and acceptability for treatment of generalized anxiety disorder among adults
  • Bupropion—myth-busting! | CNS Spectrums | Cambridge Core
    Bupropion and Anxiety Bupropion is believed to exacerbate anxiety and should not be prescribed in anxious depression This is a myth Truth is that in a meta-analysis, 5 with pooled individual patient data from 10 randomized, double-blind, placebo-controlled trials, to compare the efficacy of bupropion to SSRIs in treating anxious depression
  • Pharmacological treatments in panic disorder in adults: a network meta . . .
    We only included randomised controlled trials (a type of study in which participants are assigned to a treatment group using a random method) that compared treatment with antidepressants, benzodiazepines, azapirones and placebo in adults with a diagnosis of panic disorder, with or without agoraphobia
  • Sertraline and Bupropion in Major Depressive Disorder - Clinical Trials . . .
    Specific phobia, social anxiety disorder and generalized anxiety disorders will be allowed only if judged to be currently mild and never the principal diagnosis when co-occurring with current or past MDD Panic disorder will be allowed if MDD is the principal diagnosis and panic disorder has been in remission for > 2 years
  • Comparative efficacy and acceptability of psychotherapies for panic . . .
    In recent decades, a large number of randomised controlled trials (RCTs) have been conducted to examine the effects of psychotherapies for panic disorder 4 A Cochrane systematic review and network meta-analysis (NMA) did not find high-quality unequivocal evidence to support one psychological therapy over the others for the treatment
  • Bupropion Sustained Release for Panic Disorder
    This open prospective study provides suggestive evidence that assertions in the literature that bupropion is ineffective for panic disorder may have been premature, pending randomized, placebo-controlled study
  • Pharmacotherapy for Anxiety Disorders - Psychiatric Clinics
    Anxiety disorders are the most common psychiatric illness and include disorders such as generalized anxiety disorder (GAD), panic disorder (PD), and social anxiety disorder (SAD) Psychotherapy and pharmacotherapy are both effective treatments for anxiety disorders, with efficacy between 60% and 85% Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer